Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 18, 2026.

Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease

Andrea M. McGrattan, Bernadette McGuinness, Michelle C. McKinley and 4 more

Current Nutrition Reports · 2019 · Review

doi:10.1007/s13668-019-0271-4

Abstract

Purpose of Review. Nutrition is known to modulate the immune system and may alter neuroinflammatory processes implicated in the pathogenesis of Alzheimer’s disease (AD) and progression of neurodegeneration. Here, we review the evidence for healthy dietary patterns and age-related cognition and discuss potential neuroinflammatory actions of diet on cognitive function.

Recent Findings. Anti-inflammatory dietary patterns such as the Mediterranean diet (MD) and dietary approaches to stop hypertension (DASH) may be neuroprotective. Several dietary components consumed in the MD and DASH (omega-3 fatty acids, antioxidants and polyphenols) can inhibit neuroinflammation associated with AD. Anti-inflammatory diets may also attenuate neuroinflammation via indirect immune pathways from the gut microbiome and systemic circulation.

Summary. Diet may influence cognitive ageing via several inflammatory pathways. However, data from human studies are lacking and the exact mechanisms linking diet to cognitive function remain elusive. Further dietary intervention studies are required to investigate diet-associated neurological change from the earliest through to latest stages of cognitive decline. Furthermore, incorporation of neuroimaging measures in intervention studies would advance current understanding of the mechanistic effects of dietary modification on neuroinflammation in the ageing brain.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Worldwide, 50 million people are living with Alzheimer’s disease (AD) and related dementias, and this figure is projected to triple by 2050 unless preventive measures are developed. Addressing modifiable risk factors is considered to be the most promising strategy to prevent AD. In this regard, increasing evidence suggests that dietary interventions have potential to protect against cognitive decline during ageing.

The mechanisms governing dietary influences on cognition are not clear, but inflammatory pathways are likely to be involved. Inflammation has been strongly implicated in the pathogenesis of AD [••, ]. Microglial macrophages in the brain become chronically activated during ageing, and particularly under pathological conditions, to promote sustained production of pro-inflammatory cytokines including interleukin-1β, interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α). Production of these molecules can perpetuate a cycle of neuroinflammatory processes including amyloidosis, neuronal death, cortical thinning, reduced brain volume, cerebral vascular disease-related events such as microbleeds and infarcts and neurodegeneration [••]. Genetic studies provide strong evidence for a causative role of neuroinflammation in AD, with several mutations in microglial genes, for example, TREM2 and CD33, being independently associated with elevated AD risk. Furthermore, greater numbers of activated microglial cells and cytokines have been confirmed in brain tissue from individuals with AD.

Diet is known to modulate the immune system [••], and several nutrients and bioactive components can influence neuroinflammatory processes in animals. For example, polyphenols, unsaturated fats and antioxidant vitamins inhibit oxidative stress and neuroinflammation [, ••, ], while saturated fat promotes inflammation, particularly in the hypothalamus. However, it is not clear whether diet-induced effects on neurocognition are mediated directly by neuroinflammatory processes and/or via other immune mechanisms in vivo. An increasing body of evidence suggests that peripheral inflammation and alterations to the gut microbiome can amplify neuroinflammation and accelerate neurodegeneration [••,, ] and these external factors can also be influenced by diet.

Mechanistic studies in the brain have primarily focused on single nutrients. However, the synergistic effects of nutrients and foods when consumed together as a usual dietary pattern are likely to exert greater effects on inflammatory processes and neurodegeneration during ageing. There has been much interest in examining the Mediterranean diet (MD) and dietary approaches to stop hypertension (DASH) dietary patterns as potential strategies for dementia prevention due to their proven anti-inflammatory and cardioprotective effects. The MD and DASH have shown promising associations with slower rate of cognitive decline and reduced AD risk although results have not been consistent and evidence for a causal relationship is limited due to the small number of diet intervention studies conducted. Interestingly, more recent neuroimaging studies have shown protective effects of MD on neuronal structures and early morphological changes linked to neurodegeneration and AD.

This review aims to summarise available evidence to evaluate the role of MD and DASH dietary patterns for cognitive health and AD risk during ageing and discuss underlying inflammatory mechanisms of diet on cognitive function in humans and animal models.

The Mediterranean Diet

The MD describes the traditional dietary pattern consumed in Mediterranean countries and is characterised by high intake of fruits, vegetables, wholegrains, nuts and legumes; moderate intake of fish, poultry and alcohol (particularly red wine, with meals) and low intake of red and processed meats with olive oil used as the main fat source. Adherence to the MD has demonstrated clear benefits for both primary and secondary CVD prevention. This may also be the case for cognitive function. A recent pooled analysis of available prospective data in older adults reported a beneficial association between adherence to the MD and cognitive function, especially for domains of global cognition and episodic memory.

Observational studies that have evaluated the MD for cognitive health are summarised in Table 1. In summary, greater concordance to the MD has been associated with better cognitive performance, slower rate of cognitive decline and reduced risk of cognitive impairment and AD. However, the variable and sometimes disparate study findings are likely due to differences between studies in the populations investigated and methods used to assess diet and cognition. Most epidemiologic studies have examined MD adherence using a score system derived from population-specific median reported intake thresholds for each individual food component in the MD score and this approach limits the comparability of findings with other populations. Furthermore, there is heterogeneity between studies with regards to the cognitive outcomes measured, follow-up time and population characteristics including baseline cognitive status.

It is possible that MD contributes to neuronal integrity across the life-course. Emerging evidence from observational studies report a link between greater MD adherence and more favourable brain structures and functions that protect against neurodegeneration including increased cortical thickness, greater brain volumes, slower rate of hippocampal atrophy and improved structural connectivity as well as less amyloid (Aβ) accumulation at both midlife and older age.

The effect of MD on neurocognition has been evaluated in a limited number of randomised controlled trials (RCTs). The PREDIMED study demonstrated a modest beneficial effect of increased MD adherence over 4–6 years on cognitive function in cognitively healthy adults at high CVD risk particularly in domains of global cognition, memory and executive function. In contrast, adopting a MD over 6 months had no effect on cognitive function in healthy older Australian adults. The recent NU-AGE trial also reported no benefit of a Mediterranean-style diet on cognitive function after 1 year in older European adults; however, participants with greatest MD adherence demonstrated improved global cognition and episodic memory compared to those with low adherence.

The Dietary Approaches to Stop Hypertension Diet

The DASH diet is an accepted non-pharmacological treatment for hypertension and, like the MD, recommends a high intake of fruits, vegetables, nuts and wholegrain products. However, in contrast to a MD, DASH places greater emphasis on low fat dairy foods, low dietary sodium and does not recommend alcohol. In older adults, higher DASH scores have been associated with better cognitive function and slower cognitive decline but, again, findings have not been consistent. There is limited evidence from intervention studies for an effect of DASH on neurocognition. The ENCORE study showed improved cognitive function in response to a calorie restricted DASH diet among overweight adults with hypertension, while preliminary 6-month data from the ENLIGHTEN study in cognitively impaired adults demonstrated no benefit of DASH diet alone on cognition, but improvement in executive function among those consuming DASH combined with aerobic exercise.

Collectively, the available evidence suggests that MD and DASH patterns may provide protection against neurodegeneration during ageing, with more consistent associations in favour of the MD, probably owing to a greater number of studies that have examined MD and cognition, relative to DASH or indeed other dietary patterns. Further prospective studies in diverse populations are recommended to determine relations between dietary patterns and clinically relevant measures of cognitive decline as well as incident AD. While few dietary intervention studies have been conducted, beneficial effects of MD on cognition are shown in trials of longer duration (12 months or more) and in participants who adhere more closely to the intervention diet. Further research is required to determine the duration of dietary intervention needed for optimal effect on cognition and to identify cognitive end-point measures that can respond to subtle diet-induced changes in the ageing brain. Furthermore, intervention strategies would benefit from learning how best to support behaviour change towards a healthy dietary pattern in different population groups.

The MD and DASH dietary patterns are typically low in saturated fat, sugar and high in antioxidants, fibres and polyphenols, which have potential independent effects on brain health. It is likely that the myriad of bioactive compounds and nutrients consumed at synergistic levels within these dietary patterns exert the potential to reduce neuroinflammatory processes involved in neurodegeneration.

Effects of Diet on Neuroinflammation

Nutrients have important physiological roles for normal brain functioning and are transported into the brain via the blood–brain barrier (BBB) or from the choroid plexus transport locus of the blood-cerebrospinal fluid barrier by distinct mechanisms, such as facilitated diffusion and active transport. The effect of whole dietary patterns on neuroinflammation is yet to be discerned; however, animal studies have consistently reported anti-neuroinflammatory effects of several nutrients typically eaten in high amounts in MD and DASH diets. Antioxidants from fruit and vegetables suppress neuroinflammatory processes and neuronal apoptosis by inhibiting free radicals and cytokine production in activated microglia cells and plant-derived flavonoids are thought to play a role in preventing neuroinflammation by downregulating transcription factor activity, e.g. NF-KB and inhibiting pro-inflammatory cell signalling pathways. Long chain omega-3 fatty acids from fish attenuate the expression of pro-inflammatory cytokines in microglia and help to resolve inflammation in the brain.

While these animal studies provide important insights into mechanistic actions of diet on neuroinflammation, it is not clear how well the findings translate to humans, due to potential differences in nutrient bioavailability and metabolism. Indeed, single nutrient supplementation has shown no cognitive benefit among older adults in the few trials that have been conducted so far [•, •], although positive signals have been observed for individuals with low baseline nutrient status and for fish oil supplementation in early cognitive impairment, suggesting that population subgroups may derive cognitive benefit from nutrient supplementation.

Systemic Inflammation

Increased peripheral inflammatory markers have been associated with neurodegeneration and are suggested to increase neuroinflammation via neuronal and hormonal pathways, as previously reviewed [••, ••]. The MD and DASH diet have demonstrated anti-inflammatory effects in humans. In a recent meta-analysis of six RCTs, DASH significantly decreased serum (high-sensitivity C-reactive protein (hs-CRP) concentration (mean difference − 1.01: 95% CI − 1.64, − 0.38; I2 = 67.7%) compared to usual diet which tended to be of greater magnitude in trials with longer duration. The MD has been shown to decrease a broader range of inflammatory biomarkers. The PREDIMED study reported reductions in cytokines (IL-1, IL-6, IL-8, IL-12p70, CRP, TNF-α) and chemokines (MCP-1 and macrophage inflammatory proteins (MIP-1β)) in response to a 3-month MD supplemented with either olive oil or nuts, and the anti-inflammatory effects were observed up to 5 years of intervention. Adoption of a MD also significantly reduced hs-CRP, IL-6, IL-7, and IL-18 in patients with the metabolic syndrome. Furthermore, key components of the MD, such as oily fish and omega 3 fatty acids, as well as bioactive polyphenols found in fruits and vegetables, red wine and olive oil have also been shown to reduce pro-inflammatory markers [,, ••]. Hence, the ability of dietary patterns, particularly the MD, to decrease systemic inflammation may help to attenuate neuroinflammation.

Emerging observational data lend support to systemic inflammation as a driver between diet and neurocognition (Table 2). High pro-inflammatory dietary scores have been linked with poor cognitive performance and cognitive impairment. Moreover, a proinflammatory dietary pattern, based on circulating IL-6 and characterised by higher intake of red meat, processed meat, peas and legumes, and fried food, and lower intake of whole grains has been associated with accelerated cognitive decline, while an inflammatory nutrient pattern derived from IL-6 and CRP levels and characterised by low intake of calcium, antioxidant vitamins, omega-3 and high intake of cholesterol, has been inversely associated with brain volume and cognitive function. Further longitudinal studies are needed to evaluate whether dietary patterns based on systemic inflammatory biomarkers are related to incident AD.

The Gut Microbiome

The human gut microbiome represents the collective genomes of 10–100 trillion microorganisms harboured in the gastrointestinal tract and is considered important for healthy immune function. The ageing process and other environmental factors can result in alterations to the microbiome composition (dysbiosis) and contribute to the development of chronic low-grade inflammation. Dysbiosis stimulates excretion of endotoxins, e.g. lipopolysaccharides (LPSs) and microbial amyloids to promote permeability of the gut wall and increase peripheral circulation of proinflammatory cytokines. Dybiosis has been implicated in the pathogenesis of AD by initiating and prolonging neuroinflammatory processes. Gut-derived bacteria and toxins can compromise the integrity of the BBB and contribute to early neuroinflammatory changes and AD by priming microglia and impairing amyloid clearance. Moreover, circulating LPSs and microbial amyloid activate innate resistance receptors, e.g. toll-like receptor (TLR) and receptor for advanced glycation end-products (RAGE) to amplify pro-inflammatory signalling and promote chronic neuroinflammation and progress neurodegeneration, particularly in brain regions sensitive to AD such as the hippocampus.

Almost 60% of variation in the gut microbiome is attributable to diet; therefore, modulating the gut microbiome through dietary means could be an effective approach to reduce inflammation associated with AD. However, only few studies have evaluated dietary patterns and gut microbiota. Preliminary data has shown positive associations between the MD and increased number of beneficial microbiota species, e.g. Bacteroidetes and their short chain fatty acid metabolites that have anti-inflammatory effects. Further research is needed to understand the complex relationships between the gut microbiome and cognitive health and whether diet-induced effects on cognitive function are mediated by alterations in gut microbiota.

Conclusion

Given the lack of effective treatments and projected increased prevalence of AD, there is considerable interest in understanding the contribution of neuroinflammation to the pathogenesis of AD in order to develop effective preventive strategies for cognitive decline.

Compelling evidence shows that nutrients and other bioactive dietary compounds influence neuroinflammatory processes leading to neurodegeneration in animals and that nutrients can act synergistically to exert greater biological effects. It is plausible that diets rich in anti-inflammatory components attenuate neuroinflammation via several immune pathways within the brain and indirectly from the gut microbiome and systemic circulation. However, data from human studies are lacking and the exact inflammatory mechanisms linking diet to cognitive function remain elusive.

Growing evidence supports a protective effect of anti-inflammatory dietary patterns, especially the MD, against cognitive decline in older persons but causal associations between diet and AD remain uncertain. The evidence base has been recently strengthened by small intervention studies showing improvements in cognitive function in response to MD and calorie-controlled DASH. However, adequately powered intervention studies with larger sample sizes and longer durations are required to examine the effect of dietary modification on clinically relevant cognitive outcomes. Neuroimaging studies have shown direct beneficial associations of MD on preclinical changes associated with AD; therefore, brain biomarkers should be considered as end-points in future intervention studies to investigate diet-associated neurological change from the earliest through to latest stages of cognitive decline. Furthermore, incorporation of PET (positron emission tomography) could allow measurement of in vivo microglia activation and advance current understanding of the mechanistic effects of dietary modification on neuroinflammation in the ageing brain.

While most research attention has been given to MD and DASH, there is still much to learn about the ideal combination of foods and nutrients for optimal cognitive health during ageing. More recently, the MIND (Mediterranean-DASH diet intervention for neurodegeneration delay) dietary pattern that incorporates foods based on evidence in the diet-dementia field has shown to be more predictive of cognitive decline than the MD and has also been associated with reduced AD risk. The effect of MIND on cognitive decline is currently being evaluated in several US trials (e.g. clinicaltrials.gov Reference NCT02817074, NCT03688126) and will generate valuable data to determine whether improving diet quality is an effective strategy to improve brain health in older adults.

References 104

  1. 1.
    Dementia and aging populations-A global priority for contextualized research and health policy. · 2017
    Not checked
  2. 2.

    Martinez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvado J, San Julian B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84(12):1318-1325.

    Not in our library10.1136/jnnp-2012-304792

  3. 3.

    Smith PJ, Blumenthal JA, Babyak MA, Craighead L, Welsh-Bohmer KA, Browndyke JN, Strauman TA, Sherwood A. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55(6):1331-1338.

    Not in our library10.1161/hypertensionaha.109.146795

  4. 4.

    Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martinez-Gonzalez MA, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175(7):1094-1103.

    Not in our library10.1001/jamainternmed.2015.1668

  5. 5.

    Scarmeas N, Anastasiou CA, Yannakoulia M. Nutrition and prevention of cognitive impairment. Lancet Neurol. 2018;17(11):1006-1015.

    Not in our library10.1016/s1474-4422(18)30338-7

  6. 6.

    Vauzour D, Camprubi-Robles M, Miquel-Kergoat S, Andres-Lacueva C, Bánáti D, Barberger-Gateau P, Bowman GL, Caberlotto L, Clarke R, Hogervorst E, Kiliaan AJ, Lucca U, Manach C, Minihane AM, Mitchell ES, Perneczky R, Perry H, Roussel AM, Schuermans J, Sijben J, Spencer JPE, Thuret S, van de Rest O, Vandewoude M, Wesnes K, Williams RJ, Williams RSB, Ramirez M. Nutrition for the ageing brain: towards evidence for an optimal diet. Ageing Res Rev. 2017;35:222-240.

    Not in our library10.1016/j.arr.2016.09.010

  7. 7.

    Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388-405.

    Not in our library10.1016/s1474-4422(15)70016-5

  8. 8.

    Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16(6):358-372.

    Not in our library10.1038/nrn3880

  9. 9.

    Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol. 2008;84(4):932-939.

    Not in our library10.1189/jlb.0208108

  10. 10.

    Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer P, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, van Muiswinkel F, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21(3):383-421.

    Not in our library10.1016/s0197-4580(00)00124-x

  11. 11.

    Sastre M, Klockgether T, Heneka M. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. 2006.

    Not in our library10.1016/j.ijdevneu.2005.11.014

  12. 12.

    Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57-69.

    Not in our library10.1038/nrn2038

  13. 13.

    Gu Y, Vorburger R, Scarmeas N, Luchsinger JA, Manly JJ, Schupf N, Mayeux R, Brickman AM. Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population. Brain Behav Immun. 2017;65:150-160.

    Not in our library10.1016/j.bbi.2017.04.022

  14. 14.

    McCarrey AC, Pacheco J, Carlson OD, Egan JM, Thambisetty M, An Y, Ferrucci L, Resnick S. Interleukin-6 is linked to longitudinal rates of cortical thinning in aging. Transl Neurosci. 2014;5(1):1-7.

    Not in our library10.2478/s13380-014-0203-0

  15. 15.

    Gu Y, Gutierrez J, Meier IB, Guzman VA, Manly JJ, Schupf N, Brickman AM, Mayeux R. Circulating inflammatory biomarkers are related to cerebrovascular disease in older adults. Neurology - Neuroimmunology Neuroinflammation. 2019;6(1):e521.

    Not in our library10.1212/nxi.0000000000000521

  16. 16.

    Swardfager W, Yu D, Ramirez J, Cogo-Moreira H, Szilagyi G, Holmes MF, et al. Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report. Alzheimers Dement (Amsterdam, Netherlands). 2017;7:56-60.

    Not in our library10.1016/j.dadm.2016.12.011

  17. 17.

    Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci. 2018;21(10):1359-1369.

    Not in our library10.1038/s41593-018-0242-x

  18. 18.

    Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and Alzheimer's disease. Arch Pharm Res. 2010;33(10):1539-1556.

    Not in our library10.1007/s12272-010-1006-7

  19. 19.

    Calder PC, Bosco N, Bourdet-Sicard R, Capuron L, Delzenne N, Doré J, et al. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev. 2017;40:95-119.

    Not in our library10.1016/j.arr.2017.09.001

  20. 20.

    Devassy JG, Leng S, Gabbs M, Monirujjaman M, Aukema HM. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. Adv Nutr (Bethesda, Md). 2016;7(5):905-916.

    Not in our library10.3945/an.116.012187

  21. 21.

    Miquel S, Champ C, Day J, Aarts E, Bahr BA, Bakker M, et al. Poor cognitive ageing: vulnerabilities, mechanisms and the impact of nutritional interventions. Ageing Res Rev. 2018;42:40-55.

    Not in our library10.1016/j.arr.2017.12.004

  22. 22.
    Vitamin C, Aging and Alzheimer’s Disease · 2017
    No notice
  23. 23.

    Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, Tsukumo DML, Anhe G, Amaral ME, Takahashi HK, Curi R, Oliveira HC, Carvalheira JBC, Bordin S, Saad MJ, Velloso LA. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29(2):359-370.

    Not in our library10.1523/jneurosci.2760-08.2009

  24. 24.

    Kowalski K, Mulak A. Brain-gut-microbiota Axis in Alzheimer's disease. J Neurogastroenterol Motil. 2019;25(1):48-60.

    Not in our library10.5056/jnm18087

  25. 25.

    Pistollato F, Iglesias RC, Ruiz R, Aparicio S, Crespo J, Lopez LD, Manna PP, Giampieri F, Battino M. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies. Pharmacol Res. 2018;131:32-43.

    Not in our library10.1016/j.phrs.2018.03.012

  26. 26.
    Low-grade inflammation, diet composition and health: current research evidence and its translation · 2015
    No notice
  27. 27.

    Feart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. Jama. 2009;302(6):638-648.

    Not in our library10.1001/jama.2009.1146

  28. 28.

    Casas R, Sacanella E, Urpi-Sarda M, Corella D, Castaner O, Lamuela-Raventos RM, et al. Long-term immunomodulatory effects of a Mediterranean diet in adults at high risk of cardiovascular disease in the PREvencion con DIeta MEDiterranea (PREDIMED) randomized controlled trial. J Nutr. 2016;146(9):1684-1693.

    Not in our library10.3945/jn.115.229476

  29. 29.

    Casas R, Urpi-Sardà M, Sacanella E, Arranz S, Corella D, Castañer O, et al. Anti-Inflammatory Effects of the Mediterranean Diet in the Early and Late Stages of Atheroma Plaque Development. Mediat Inflamm. 2017;2017:3674390.

    Not in our library10.1155/2017/3674390

  30. 30.

    Soltani S, Chitsazi MJ, Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: a systematic review and meta-analysis of randomized trials. Clin Nutr. 2018;37(2):542-550.

    Not in our library10.1016/j.clnu.2017.02.018

  31. 31.

    Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, Simons-Morton D, McCullough M, Swain J, Steele P, Evans MA, Miller ER, Harsha DW. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med. 1997;336(16):1117-1124.

    Not in our library10.1056/nejm199704173361601

  32. 32.

    Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34.

    Not in our library10.1056/nejmoa1800389

  33. 33.

    Tangney CC, Li H, Wang Y, Barnes L, Schneider JA, Bennett DA, Morris MC. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology. 2014;83(16):1410-1416.

    Not in our library10.1212/wnl.0000000000000884

  34. 34.

    van de Rest O, Berendsen AA, Haveman-Nies A, de Groot LC. Dietary patterns, cognitive decline, and dementia: a systematic review. Adv Nutr. 2015;6(2):154-168.

    Not in our library10.3945/an.114.007617

  35. 35.

    Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, Llewellyn DJ. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology. 2013;24(4):479-489.

    Not in our library10.1097/ede.0b013e3182944410

  36. 36.

    Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59(6):912-921.

    Not in our library10.1002/ana.20854

  37. 37.

    Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, Roberts RO. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimer's Dis: JAD. 2014;39(2):271-282.

    Not in our library10.3233/jad-130830

  38. 38.
    Adherence to Mediterranean diet and risk of developing cognitive disorders: An updated systematic review and meta-analysis of prospective cohort studies · 2017
    No notice
  39. 39.

    Olsson E, Karlstrom B, Kilander L, Byberg L, Cederholm T, Sjogren P. Dietary patterns and cognitive dysfunction in a 12-year follow-up study of 70 year old men. J Alzheimers Dis. 2015;43(1):109-119.

    Not in our library10.3233/jad-140867

  40. 40.

    Samieri C, Grodstein F, Rosner BA, Kang JH, Cook NR, Manson JE, et al. Mediterranean diet and cognitive function in older age. Epidemiology. 2013;24(4):490-499.

    Not in our library10.1097/ede.0b013e318294a065

  41. 41.

    Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Mosconi L. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. Neurology. 2018;90(20):e1789-e1e98.

    Not in our library10.1212/wnl.0000000000005527

  42. 42.

    Gu Y, Brickman AM, Stern Y, Habeck CG, Razlighi QR, Luchsinger JA, Manly JJ, Schupf N, Mayeux R, Scarmeas N. Mediterranean diet and brain structure in a multiethnic elderly cohort. Neurology. 2015;85(20):1744-1751.

    Not in our library10.1212/wnl.0000000000002121

  43. 43.

    Gu Y, Scarmeas N, Stern Y, Manly JJ, Schupf N, Mayeux R, Brickman AM. Mediterranean diet is associated with slower rate of hippocampal atrophy: a longitudinal study in cognitively normal older adults. Alzheimers Dement. 2016;12(7):P193-P1P4.

    Not in our library

  44. 44.

    Luciano M, Corley J, Cox SR, Valdés Hernández MC, Craig LCA, Dickie DA, Karama S, McNeill GM, Bastin ME, Wardlaw JM, Deary IJ. Mediterranean-type diet and brain structural change from 73 to 76 years in a Scottish cohort. Neurology. 2017;88(5):449-455.

    Not in our library10.1212/wnl.0000000000003559

  45. 45.

    Mosconi L, Murray J, Tsui WH, Li Y, Davies M, Williams S, Pirraglia E, Spector N, Osorio RS, Glodzik L, McHugh P, de Leon MJ. Mediterranean diet and magnetic resonance imaging-assessed brain atrophy in cognitively Normal individuals at risk for Alzheimer's disease. J Prev Alzheimers Dis. 2014;1(1):23-32.

    Not in our library

  46. 46.

    Pelletier A, Barul C, Feart C, Helmer C, Bernard C, Periot O, et al. Mediterranean diet and preserved brain structural connectivity in older subjects. Alzheimers Dement. 2015;11(9):1023-1031.

    Not in our library10.1016/j.jalz.2015.06.1888

  47. 47.

    Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, et al. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Transl Psychiatry. 2018;8(1):238.

    Not in our library10.1038/s41398-018-0293-5

  48. 48.

    Staubo SC, Aakre JA, Vemuri P, Syrjanen JA, Mielke MM, Geda YE, Kremers WK, Machulda MM, Knopman DS, Petersen RC, Jack CR, Roberts RO. Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement. 2017;13(2):168-177.

    Not in our library10.1016/j.jalz.2016.06.2359

  49. 49.

    Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A, Dernini S, Medina FX, Battino M, Belahsen R, Miranda G, Serra-Majem L, Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14(12a):2274-2284.

    Not in our library10.1017/s1368980011002515

  50. 50.
    Definition of the Mediterranean Diet; A Literature Review · 2015
    No notice
  51. 51.

    de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation. 1999;99(6):779-785.

    Not in our library10.1161/01.cir.99.6.779

  52. 52.

    Loughrey DG, Lavecchia S, Brennan S, Lawlor BA, Kelly ME. The impact of the Mediterranean diet on the cognitive functioning of healthy older adults: a systematic review and meta-analysis. Adv Nutr. 2017;8(4):571-586.

    Not in our library10.3945/an.117.015495

  53. 53.

    Katsiardanis K, Diamantaras AA, Dessypris N, Michelakos T, Anastasiou A, Katsiardani KP, Kanavidis P, Papadopoulos FC, Stefanadis C, Panagiotakos DB, Petridou ET. Cognitive impairment and dietary habits among elders: the Velestino study. J Med Food. 2013;16(4):343-350.

    Not in our library10.1089/jmf.2012.0225

  54. 54.

    Kesse-Guyot E, Andreeva VA, Lassale C, Ferry M, Jeandel C, Hercberg S, et al. Mediterranean diet and cognitive function: a French study. Am J Clin Nutr. 2013;97(2):369-376.

    Not in our library10.3945/ajcn.112.047993

  55. 55.

    Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66(2):216-225.

    Not in our library10.1001/archneurol.2008.536

  56. 56.

    Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Transl Psychiatry. 2012;2(10):e164-e.

    Not in our library10.1038/tp.2012.91

  57. 57.

    Zbeida M, Goldsmith R, Shimony T, Vardi H, Naggan L, Shahar DR. Mediterranean diet and functional indicators among older adults in non-Mediterranean and Mediterranean countries. J Nutr Health Aging. 2014;18(4):411-418.

    Not in our library10.1007/s12603-014-0003-9

  58. 58.

    McEvoy CT, Guyer H, Langa KM, Yaffe K. Neuroprotective diets are associated with better cognitive function: the health and retirement study. J Am Geriatr Soc. 2017;65(8):1857-1862.

    Not in our library10.1111/jgs.14922

  59. 59.

    Psaltopoulou T, Kyrozis A, Stathopoulos P, Trichopoulos D, Vassilopoulos D, Trichopoulou A. Diet, physical activity and cognitive impairment among elders: the EPIC-Greece cohort (European prospective investigation into Cancer and nutrition). Public Health Nutr. 2008;11(10):1054-1062.

    Not in our library10.1017/s1368980007001607

  60. 60.

    Roberts RO, Geda YE, Cerhan JR, Knopman DS, Cha RH, Christianson TJ, et al. Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;29(5):413-423.

    Not in our library10.1159/000305099

  61. 61.

    Tsivgoulis G, Judd S, Letter AJ, Alexandrov AV, Howard G, Nahab F, Unverzagt FW, Moy C, Howard VJ, Kissela B, Wadley VG. Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology. 2013;80(18):1684-1692.

    Not in our library10.1212/wnl.0b013e3182904f69

  62. 62.

    Cherbuin N, Anstey KJ. The Mediterranean diet is not related to cognitive change in a large prospective investigation: the PATH through life study. Am J Geriatr Psychiatry. 2012;20(7):635-639.

    Not in our library10.1097/jgp.0b013e31823032a9

  63. 63.

    Titova OE, Ax E, Brooks SJ, Sjogren P, Cederholm T, Kilander L, et al. Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes. Exp Gerontol. 2013;48(12):1443-1448.

    Not in our library10.1016/j.exger.2013.10.002

  64. 64.

    Vercambre MN, Grodstein F, Berr C, Kang JH. Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors. J Acad Nutr Diet. 2012;112(6):816-823.

    Not in our library10.1016/j.jand.2012.02.023

  65. 65.

    Samieri C, Okereke OI. E ED, Grodstein F. Long-term adherence to the Mediterranean diet is associated with overall cognitive status, but not cognitive decline, in women. J Nutr. 2013;143(4):493-499.

    Not in our library10.3945/jn.112.169896

  66. 66.

    Galbete C, Toledo E, Toledo JB, Bes-Rastrollo M, Buil-Cosiales P, Marti A, Guillén-Grima F, Martínez-González MA. Mediterranean diet and cognitive function: the sun project. J Nutr Health Aging. 2015;19(3):305-312.

    Not in our library10.1007/s12603-015-0441-z

  67. 67.

    Qin B, Adair LS, Plassman BL, Batis C, Edwards LJ, Popkin BM, Mendez MA. Dietary patterns and cognitive decline among Chinese older adults. Epidemiology. 2015;26(5):758-768.

    Not in our library10.1097/ede.0000000000000338

  68. 68.

    Anastasiou CA, Yannakoulia M, Kontogianni MD, Kosmidis MH, Mamalaki E, Dardiotis E, Hadjigeorgiou G, Sakka P, Tsapanou A, Lykou A, Scarmeas N. Mediterranean lifestyle in relation to cognitive health: results from the HELIAD study. Nutrients. 2018;10(10):1557.

    Not in our library10.3390/nu10101557

  69. 69.

    Wengreen H, Munger RG, Cutler A, Quach A, Bowles A, Corcoran C, Tschanz JAT, Norton MC, Welsh-Bohmer KA. Prospective study of dietary approaches to stop hypertension- and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County study on memory, health and aging. Am J Clin Nutr. 2013;98(5):1263-1271.

    Not in our library10.3945/ajcn.112.051276

  70. 70.

    Haring B, Wu C, Mossavar-Rahmani Y, Snetselaar L, Brunner R, Wallace RB, et al. No Association between Dietary Patterns and Risk for Cognitive Decline in Older Women with 9-Year Follow-Up: Data from the Women's Health Initiative Memory Study. J Acad Nutr Diet. 2016;116(6):921–30.e1.

    Not in our library10.1016/j.jand.2015.12.017

  71. 71.

    Martinez-Lapiscina EH, Clavero P, Toledo E, San Julian B, Sanchez-Tainta A, Corella D, Lamuela-Raventos RM, Martinez JA, Martinez-Gonzalez MÁ. Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging. 2013;17(6):544-552.

    Not in our library10.1007/s12603-013-0027-6

  72. 72.

    Knight A, Bryan J, Wilson C, Hodgson JM, Davis CR, Murphy KJ. The Mediterranean diet and cognitive function among healthy older adults in a 6-month randomised controlled trial: the MedLey study. Nutrients. 2016;8(9):579.

    Not in our library10.3390/nu8090579

  73. 73.

    Marseglia A, Xu W, Fratiglioni L, Fabbri C, Berendsen AAM, Bialecka-Debek A, et al. Effect of the NU-AGE Diet on Cognitive Functioning in Older Adults: A Randomized Controlled Trial. Front Physiol. 2018;9:349.

    Not in our library10.3389/fphys.2018.00349

  74. 74.

    Blumenthal J, Smith P, Mabe S, Hinderliter A, Lin P-H, Liao L, et al. Lifestyle and neurocognition in older adults with cognitive impairments: a randomized trial. 2018.

    Not in our library10.1212/wnl.0000000000006784

  75. 75.

    Lau FC, Shukitt-Hale B, Joseph JA. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell Biochem. 2007;42:299-318.

    Not in our library

  76. 76.

    Spector R. Nutrient transport systems in brain: 40 years of progress. J Neurochem. 2009;111(2):315-320.

    Not in our library10.1111/j.1471-4159.2009.06326.x

  77. 77.

    Mohammadzadeh Honarvar N, Saedisomeolia A, Abdolahi M, Shayeganrad A, Taheri Sangsari G, Hassanzadeh Rad B, Muench G. Molecular anti-inflammatory mechanisms of Retinoids and carotenoids in Alzheimer's disease: a review of current evidence. J Mol Neurosci. 2017;61(3):289-304.

    Not in our library10.1007/s12031-016-0857-x

  78. 78.

    Flanagan E, Müller M, Hornberger M, Vauzour D. Impact of flavonoids on cellular and molecular mechanisms underlying age-related cognitive decline and neurodegeneration. Curr Nutr Rep. 2018;7(2):49-57.

    Not in our library10.1007/s13668-018-0226-1

  79. 79.

    Rendeiro C, Rhodes JS, Spencer JP. The mechanisms of action of flavonoids in the brain: direct versus indirect effects. Neurochem Int. 2015;89:126-139.

    Not in our library10.1016/j.neuint.2015.08.002

  80. 80.

    Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771-785.

    Not in our library10.1038/nrn3820

  81. 81.

    • Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev. 2016;(4). 10.1002/14651858.CD009002.pub3An evaluation of the efficacy of omega-3 supplementation in dementia.

    Not in our library10.1002/14651858.cd009002.pub3

  82. 82.

    • McCleery J, Abraham R, Denton D, Rutjes A, Chong LY. S Al-Assaf a et al. vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Cochrane Database Syst Rev. 2018;(11). 10.1002/14651858.CD011905.pub2An evalauation of the effects of vitamin and mineral supplementation on cognitive function and the incidence of dementia in people with mild cognitive impairment.

    Not in our library10.1002/14651858.cd011905.pub2

  83. 83.

    Morris M, Tangney C. A potential design flaw of randomized trials of vitamin supplements. 2011.

    Not in our library10.1001/jama.2011.383

  84. 84.

    Freund-Levi Y, Eriksdotter M, Cederholm T, Basun H, Irving G, Garlind A, et al. n-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study. 2006.

    Not in our library10.1001/archneur.63.10.1402

  85. 85.

    Koyama A, Yaffe K, O’Brien J, Blacker D, Weuve J, Metti AL. The role of peripheral inflammatory markers in dementia and Alzheimer’s disease: a meta-analysis. J Gerontol: Series A. 2012;68(4):433-440.

    Not in our library10.1093/gerona/gls187

  86. 86.

    Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440-1446.

    Not in our library10.1001/jama.292.12.1440

  87. 87.

    Casas R, Sacanella E, Estruch R. The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocr Metab Immune Disord Drug Targets. 2014;14(4):245-254.

    Not in our library10.2174/1871530314666140922153350

  88. 88.

    Vauzour D, Martinsen A, Laye S. Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects? Neurochem Int. 2015;89:63-74.

    Not in our library10.1016/j.neuint.2015.08.004

  89. 89.
    Dietary pattern, inflammation and cognitive decline: The Whitehall II prospective cohort study · 2017
    No notice
  90. 90.

    Gu Y, Manly JJ, Mayeux RP, Brickman AM. An inflammation-related nutrient pattern is associated with both brain and cognitive measures in a multiethnic elderly population. Curr Alzheimer Res. 2018;15(5):493-501.

    Not in our library10.2174/1567205015666180101145619

  91. 91.

    Kesse-Guyot E, Assmann KE, Andreeva VA, Touvier M, Neufcourt L, Shivappa N, Hébert JR, Wirth MD, Hercberg S, Galan P, Julia C. Long-term association between the dietary inflammatory index and cognitive functioning: findings from the SU.VI.MAX study. Eur J Nutr. 2017;56(4):1647-1655.

    Not in our library10.1007/s00394-016-1211-3

  92. 92.

    Shin D, Kwon SC, Kim MH, Lee KW, Choi SY, Shivappa N, et al. Inflammatory potential of diet is associated with cognitive function in an older adult Korean population. Nutrition. 2018;55–56:56-62.

    Not in our library10.1016/j.nut.2018.02.026

  93. 93.

    Hayden KM, Beavers DP, Steck SE, Hebert JR, Tabung FK, Shivappa N, Casanova R, Manson JAE, Padula CB, Salmoirago-Blotcher E, Snetselaar LG, Zaslavsky O, Rapp SR. The association between an inflammatory diet and global cognitive function and incident dementia in older women: the Women's Health Initiative memory study. Alzheimers Dement. 2017;13(11):1187-1196.

    Not in our library10.1016/j.jalz.2017.04.004

  94. 94.

    Frith E, Shivappa N, Mann JR, Hebert JR, Wirth MD, Loprinzi PD. Dietary inflammatory index and memory function: population-based national sample of elderly Americans. Br J Nutr. 2018;119(5):552-558.

    Not in our library10.1017/s0007114517003804

  95. 95.

    Clemente JC, Manasson J, Scher JU. The role of the gut microbiome in systemic inflammatory disease. Bmj. 2018;360:j5145.

    Not in our library10.1136/bmj.j5145

  96. 96.

    Power SE, O'Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr. 2014;111(3):387-402.

    Not in our library10.1017/s0007114513002560

  97. 97.
    A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia · 2015
    No notice
  98. 98.
    The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review · 2018
    No notice
  99. 99.
    The role of intestinal microbiota in cardiovascular disease · 2019
    No notice
  100. 100.
    Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population · 2018
    No notice
  101. 101.

    Gutierrez-Diaz I, Fernandez-Navarro T, Sanchez B, Margolles A, Gonzalez S. Mediterranean diet and faecal microbiota: a transversal study. Food Funct. 2016;7(5):2347-2356.

    Not in our library10.1039/c6fo00105j

  102. 102.

    Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics. 2007;4(3):443-452.

    Not in our library10.1016/j.nurt.2007.04.006

  103. 103.

    Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, Aggarwal NT. MIND diet slows cognitive decline with aging. Alzheimer's Dement: J Alzheimer's Assoc. 2015;11(9):1015-1022.

    Not in our library10.1016/j.jalz.2015.04.011

  104. 104.

    Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's Dement: J Alzheimer's Assoc. 2015;11(9):1007-1014.

    Not in our library10.1016/j.jalz.2014.11.009

Cited by papers we hold 6

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.